RT Book, Section
A1 Tsutaoka, Ben
A2 Olson, Kent R.
A2 Anderson, Ilene B.
A2 Benowitz, Neal L.
A2 Blanc, Paul D.
A2 Clark, Richard F.
A2 Kearney, Thomas E.
A2 Kim-Katz, Susan Y.
A2 Wu, Alan H. B.
SR Print(0)
ID 1174605283
T1 BENZODIAZEPINES
T2 Poisoning & Drug Overdose, 7e
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071839792
LK accessmedicine.mhmedical.com/content.aspx?aid=1174605283
RD 2024/10/05
AB The  drug  class  of  benzodiazepines  includes  many  compounds  that  vary  widely  in  potency,  duration  of  effect,  the  presence  or  absence  of  active  metabolites,  and  clinical  use  (Table  II–14).  Three  nonbenzodiazepines—eszopiclone,  zaleplon,  and  zolpidem—have  similar  clinical  effects  and  are  included  here.  In  general,  death  from  benzodiazepine  overdose  is  rare  unless  the  drugs  are  combined  with  other  CNS-depressant  agents,  such  as  ethanol,  opioids,  and  barbiturates.  Newer  potent,  short-acting  agents  have  been  considered  the  sole  cause  of  death  in  recent  forensic  cases.